Cantor Fitzgerald, L. P. »

Aclaris Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2025-06-30 $641k 451k 1.42
2025-03-31 $1.1M 696k 1.53
2024-12-31 $248k 100k 2.48

More positions owned by Cantor Fitzgerald, L. P.

Strategy Cl A (MSTR)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Robinhood Mkts Com Cl A (HOOD)
Super Micro Computer Inc Com Usd0.001 (SMCI)
UnitedHealth (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Rocket Lab Corp (RKLB)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Oracle Corporation (ORCL)
Oklo Com Cl A (OKLO)
Broadcom (AVGO)
Rigetti Computing Common Stock (RGTI)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Aclaris Therapeutics

BML Capital Management
Vivo Capital
Vanguard Group
BlackRock
Adage Capital Partners GP
Rock Springs Capital Management
Decheng Capital
Morgan Stanley
Geode Capital Management
D. E. Shaw & Co
Acadian Asset Management
Marshall Wace
Renaissance Technologies
Palo Alto Investors
Millennium Management

View all funds holding Aclaris Therapeutics